FibroBiologics, Inc. Common Stock
FibroBiologics, Inc. Common Stock (FBLG) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · FBLG · as of Jun 9, 2026
Activity summary
Buy transactions
8
P-Purchase only
Sell transactions
0
12 Months
Buy/Sell ratio
∞
Buy/Sell (by trades)
Overall sentiment
FibroBiologics, Inc. Common Stock insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
FBLG insider buying and selling by quarter
FBLG insider selling · FBLG insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Active insiders
Most active in past 12 months · FBLG ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
FBLG executive sell shares · FBLG board member insider trading · FBLG insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Mar 4, 2026 | Khoja Hamid Chief Scientific Officer | Purchase | 30,000 | $11K | Form 4 |
| Mar 4, 2026 | O'HEERON PETE CHIEF EXECUTIVE OFFICER · Director | Purchase | 15,872 | $6K | Form 4 |
| Mar 3, 2026 | O'HEERON PETE CHIEF EXECUTIVE OFFICER · Director | Purchase | 18,200 | $7K | Form 4 |
| Mar 2, 2026 | O'HEERON PETE CHIEF EXECUTIVE OFFICER · Director | Purchase | 17,428 | $6K | Form 4 |
| Mar 2, 2026 | Davis Jason CFO | Purchase | 70,000 | $29K | Form 4 |
| Feb 27, 2026 | GARCIA RUBEN A General Counsel | Purchase | 40,000 | $13K | Form 4 |
| Dec 11, 2025 | GARCIA RUBEN A General Counsel | Purchase | 140,000 | $48K | Form 4 |
| May 27, 2025 | Khoja Hamid Chief Scientific Officer | Purchase | 20,000 | $17K | Form 4 |
| Dec 9, 2024 | O'HEERON PETE CEO · Director | Gift | 100,000 | — | Form 4 |
| Dec 3, 2024 | O'HEERON PETE CEO · Director | Gift | 50,000 | — | Form 4 |
Khoja Hamid
Chief Scientific Officer
Date
Mar 4
Shares
30,000
Price
$0.38
Value
$11K
O'HEERON PETE
CHIEF EXECUTIVE OFFICER · Director
Date
Mar 4
Shares
15,872
Price
$0.38
Value
$6K
O'HEERON PETE
CHIEF EXECUTIVE OFFICER · Director
Date
Mar 3
Shares
18,200
Price
$0.41
Value
$7K
O'HEERON PETE
CHIEF EXECUTIVE OFFICER · Director
Date
Mar 2
Shares
17,428
Price
$0.35
Value
$6K
GARCIA RUBEN A
General Counsel
Date
Feb 27
Shares
40,000
Price
$0.33
Value
$13K
GARCIA RUBEN A
General Counsel
Date
Dec 11
Shares
140,000
Price
$0.34
Value
$48K
Khoja Hamid
Chief Scientific Officer
Date
May 27
Shares
20,000
Price
$0.84
Value
$17K
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About FBLG insider trading
FBLG insider trades
FibroBiologics, Inc. Common Stock (FBLG) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including O'HEERON PETE (CHIEF EXECUTIVE OFFICER · Director), GARCIA RUBEN A (General Counsel), Khoja Hamid (Chief Scientific Officer). Over the past 12 months, 4 insiders have filed transactions with the SEC. FBLG insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For FibroBiologics, Inc. Common Stock's institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
FBLG insider trading · 5 questionsThe insiders of FibroBiologics, Inc. Common Stock (FBLG) include executives and directors such as O'HEERON PETE (CHIEF EXECUTIVE OFFICER · Director), GARCIA RUBEN A (General Counsel), Khoja Hamid (Chief Scientific Officer), among others. Over the past 12 months, 4 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026